American Oriental Bioengineering Reports Second Quarter 2009 Financi...(December 31 2008 maycause actual results...)

           AMERICAN ORIENTAL BIOENGINEERING, INC. AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS

                    ASSETS

                                                 JUNE 30,         DECEMBER 31,
                                                   2009              2008
                                                (UNAUDITED)
    CURRENT ASSETS
    Cash and cash equivalents                  $100,730,402       $70,636,510
    Accounts receivable, net of reserve of
     $505,433 and $226,330 at June 30, 2009
     and December 31, 2008, respectively         31,396,881        36,982,167
    Inventories, net                             16,829,834        13,042,123
    Advances to suppliers                         3,135,694         3,593,979
    Notes receivable                                 81,075           708,076
    Refundable deposit                                   --         6,396,996
    Deferred tax assets                             421,660           347,216
    Other current assets                            937,087           744,903
    Total Current Assets                        153,532,633       132,451,970

    LONG-TERM ASSETS
    Property, plant and equipment, net           96,151,689        98,154,443
    Land use rights, net                        148,301,203       148,988,870
    Deposit for long-term assets                  6,717,514         6,347,174
    Construction in progress                     25,871,656        25,385,835
    Deferred tax assets                           1,327,627         1,313,832
    Other intangible assets, net              
'/>"/>
SOURCE  American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 
Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance